Here's a roundup of top developments in the biotech space over the last 24 hours.
Stocks In Focus
Pfizer, BioNTech Initiates Study Of Omicron-Based Vaccine Candidate
Pfizer, Inc.(NYSE:PFE) andBioNTech SE(NASDAQ:BNTX) announced the initiation of a clinical study to evaluate the safety, tolerability and immunogenicity of an omicron-based vaccine candidate in healthy adults 18 through 55 years of age. The study will have three cohorts examining different regimens of the current Pfizer-BioNTech COVID-19 vaccine or an Omicron-based vaccine.
Opiant Announces Award of Incremental $2.2M BARDA Funding For Opioid Overdose Drug
Opiant Pharmaceuticals, Inc.(NASDAQ:OPNT...
Login or create a forever free account to read this news
Sign up/Log in
Comment(0)
Reason For Report